Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Natalia V. Chebotareva
265  Ergebnisse:
Personensuche X
?
1

Comparison of thrombodynamic methods and routine hemostasis..:

Chebotareva, Natalia V. ; Kharionovskaya, Evgenia A. ; Biryukova, Evgenia A...
Terapevticheskii arkhiv.  96 (2024)  6 - p. 565-570 , 2024
Link: https://doi.org/10.26442..
 
?
2

Gout: from Hippocrates till the modern time:

Guliaev, Sergei V. ; Chebotareva, Natalia V. ; Moiseev, Sergey V.
Terapevticheskii arkhiv.  94 (2023)  12 - p. 1438-1441 , 2023
Link: https://doi.org/10.26442..
 
?
3

Study of urinary markers of different podocytopathies by pr..:

Vinogradov, Anatoliy A. ; Chebotareva, Natalia V. ; Bugrova, Anna E....
Terapevticheskii arkhiv.  95 (2023)  6 - p. 457-561 , 2023
Link: https://doi.org/10.26442..
 
?
4

Targeted MRM Quantification of Urinary Proteins in Chronic ..:

Kononikhin, Alexey S. ; Brzhozovskiy, Alexander G. ; Bugrova, Anna E....
Molecules.  28 (2023)  8 - p. 3323 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Evaluation of hemostasis disorders using the thrombodynamic..:

Berns, Angelina S. ; Sovetnikov, Egor N. ; Chebotareva, Natalia V....
Terapevticheskii arkhiv.  94 (2022)  6 - p. 738-742 , 2022
Link: https://doi.org/10.26442..
 
?
6

NGAL and KIM-1 – early urinary biomarkers of nephrotoxicity..:

Grechukhina, Katerina S. ; Chebotareva, Natalia V. ; Zhukova, Liudmila G...
Journal of Modern Oncology.  24 (2022)  1 - p. 119-124 , 2022
Link: https://doi.org/10.26442..
 
?
7

Risk factors of kidney injury in patients with COVID-19:

Shchepalina, Anastasia A. ; Chebotareva, Natalia V. ; Kitbalian, Aram A....
Terapevticheskii arkhiv.  94 (2022)  6 - p. 743-747 , 2022
Link: https://doi.org/10.26442..
 
?
8

Urinary biomarkers of kidney injury in patients treated wit..:

Grechukhina, Katerina S. ; Chebotareva, Natalia V. ; Zhukova, Liudmila G....
Terapevticheskii arkhiv.  94 (2022)  6 - p. 725-730 , 2022
Link: https://doi.org/10.26442..
 
?
9

Potential Urine Proteomic Biomarkers for Focal Segmental Gl..:

Chebotareva, Natalia V. ; Vinogradov, Anatoliy ; Brzhozovskiy, Alexander G....
International Journal of Molecular Sciences.  23 (2022)  20 - p. 12607 , 2022
Link: https://doi.org/10.3390/..
 
?
10

Diagnostic and treatment difficulties in kidney damage in t..:

Lebedeva, Marina V. ; Chebotareva, Natalia V. ; Beketov, Vladimir D.
Terapevticheskii arkhiv.  94 (2022)  6 - p. 769-771 , 2022
Link: https://doi.org/10.26442..
 
?
11

Methotrexate-induced lung damage in a patient with rheumato..:

Ponomareva, Liubov A. ; Gurova, Daria V. ; Popova, Elena N....
Terapevticheskii arkhiv.  93 (2021)  3 - p. 295-299 , 2021
Link: https://doi.org/10.26442..
 
?
12

Historical aspects of etiopathogenesis and treatment of syp..:

Chebotarev, Vyacheslav V. ; Zemtsov, Mikhail A. ; Odinets, Alexey V..
Vestnik dermatologii i venerologii.  97 (2021)  1 - p. 8-15 , 2021
Link: https://doi.org/10.25208..
 
?
13

Role of the intestinal MALT in pathogenesis of the IgA-neph..:

Guliaev, Sergei V. ; Strizhakov, Leonid A. ; Chebotareva, Natalia V..
Terapevticheskii arkhiv.  93 (2021)  6 - p. 724-728 , 2021
Link: https://doi.org/10.26442..
 
?
14

The Rehberg–Tareev test in assessing the glomerular filtrat..:

Bobkova, Irina N. ; Kamyshova, Elena S. ; Chebotareva, Natalia V.
Terapevticheskii arkhiv.  93 (2021)  10 - p. 1246-1248 , 2021
Link: https://doi.org/10.26442..
 
?
15

Clinical and laboratory signs and risk factors for nephroto..:

Grechukhina, Katerina S. ; Chebotareva, Natalia V. ; Zhukova, Liudmila G..
Terapevticheskii arkhiv.  93 (2021)  6 - p. 661-666 , 2021
Link: https://doi.org/10.26442..
 
1-15